Member News

New blood test for prostate cancer is highly-accurate and avoids invasive biopsies

In combination with the current prostate specific antigen (PSA) test, the new test could help men avoid unnecessary and invasive biopsies, over-diagnosis and over-treatment.

Prostate cancer is the most common cancer in Western men, with 1.3 million new cases being diagnosed each year worldwide. It is currently detected using a blood test that measures PSA levels. Although it provides early diagnosis, the PSA blood test has a low specificity (high false positives) with about 75 per cent of all PSA positive results ending up with negative biopsies that do not find cancer.  

How NOT to get a Bioinformatics Patent

Multidisciplinary inventions have become more commonplace in recent years, particularly as artificial intelligence (AI) is being used as a tool in a wide range of biotech applications, such as medical image analysis and drug discovery. However, whereas biotech inventions may generally be considered to relate to inherently patentable subject matter, biotech inventions that are implemented using a computer or AI may have an additional hurdle to pass.

Economic Intelligence Wales’ first annual report highlights confidence in Welsh business sector despite UK uncertainty

Small to medium enterprises (SMEs) in Wales have higher levels of confidence than their UK counterparts, despite challenging business conditions and increasing uncertainty of UK and global economic prospects, according to the first annual report published by Economic Intelligence Wales (EIW) today.

The new research unit is a collaboration between Cardiff Business School, the Office for National Statistics and the Development Bank of Wales, created to monitor the activity of Welsh SMEs, factors affecting their development and the progress of the regional economy.